Inhaled iloprost for the treatment of Raynaud's phenomenon.
Angéla Pákozdi(Barts Health NHS Trust), CP Denton(The Royal Free Hospital), Kevin Howell, Stewart Fox, CM Black, L. Berlanga González, Hugh Wilson
PubMed
February 5, 2009
Cited by 10
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
|European Neurology|2008|99
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
|Annals of the Rheumatic Diseases|2006|98